M1A.269

Clinical Causes: Use of medications that increase uric acid levels, such as diuretics (e.g., thiazides and loop diuretics). Certain immunosuppressants like cyclosporine. Drugs that impair renal function and uric acid excretion. Long-term use of medications that alter purine metabolism. Inappropriate medication management leading to elevated serum uric acid levels.

Key Symptoms: Persistent swelling and tenderness in the knee joint. Recurrent episodes of joint pain, especially at night. Reduced joint mobility due to swelling and stiffness. Visual deposits of uric acid crystals, known as tophi, around the knee area in chronic cases. Erythema (redness) and warmth over the affected joint. Chronic joint damage and deformity if untreated over time.

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. To confirm drug-induced gout, healthcare providers consider patient history, especially medication use, alongside the following diagnostics: - Joint fluid analysis: Extraction of joint fluid to identify uric acid crystals under a microscope. - Serum uric acid levels: Elevated levels support the diagnosis but are not definitive alone. - Imaging studies: X-rays or ultrasound may show tophi or joint damage characteristic of gout. - Review of medication history to establish causative agents. A diagnosis of chronic gout usually requires repeated episodes or persistent joint changes, indicating a long-standing condition.

Treatment Protocols: Management focuses on controlling symptoms, reducing uric acid levels, and addressing medication-related causes: - Adjust or discontinue medications contributing to increased uric acid, under medical supervision. - Use of anti-inflammatory drugs such as NSAIDs for acute flare relief. - Colchicine or corticosteroids may be used for inflammation control. - Long-term urate-lowering therapy (e.g., allopurinol, febuxostat) to maintain uric acid levels below crystallization thresholds. - Lifestyle modifications, including dietary adjustments to reduce purine intake, alcohol reduction, and increased hydration. - Regular medical monitoring to evaluate uric acid levels and joint health. Treatment plans should be personalized, considering the patient's overall health and medication regimen.